Healthleap raised $38 million in combined seed and Series A funding to expand its clinical AI platform, which helps hospitals identify patients with conditions that may otherwise go undiagnosed. The financing came from Sequoia Capital, First Round Capital, and Hummingbird Ventures.
Healthleap plans to use the funding to expand into additional clinical conditions and grow its engineering, sales, customer success, and product teams.
The company currently works with more than 50 hospitals, including Penn Medicine, Houston Methodist, Cedars-Sinai, and Emory Healthcare.
Its platform screens every adult inpatient each day by analyzing the patient’s full medical record and identifying people who may require additional clinical attention.
Healthleap said the system reviews information including clinical notes, laboratory results, vital signs, orders, and problem lists before generating risk scores that are integrated into hospital electronic health record workflows.
The company initially focused on malnutrition, a condition that it says costs the U.S. healthcare system as much as $58 billion annually.
Healthleap said traditional hospital screening for malnutrition frequently relies on limited information collected during admission and can miss patients who are unable to provide accurate responses because they are sedated, confused, or critically ill.
The company cited research indicating that as many as half of hospitalized patients may be at risk for malnutrition while fewer than 9% receive a formal diagnosis.
Healthleap’s AI system is designed to continuously reassess patients throughout their hospital stay rather than relying on a one-time screening.
The company said this approach can help clinicians identify at-risk patients earlier, improve treatment, shorten hospital stays, and increase reimbursement for care that is already being delivered.
One Penn Medicine hospital reported that Healthleap generated an estimated $23.8 million annually through a combination of incremental reimbursement and the financial impact of reduced lengths of stay.
Healthleap also said another deployment identified and treated 39% more malnutrition cases and generated $11 million in incremental revenue across a health system.
The company is now expanding its technology beyond malnutrition into conditions including congestive heart failure, pressure ulcers, and hospital-acquired infections.
Healthleap said the broader goal is to create an AI-powered screening layer that can continuously evaluate patients for multiple conditions and route relevant findings directly into clinicians’ existing workflows.
The platform is HIPAA compliant and SOC 2 certified.
Healthleap was founded in 2022 by siblings Josiah Meyer and Jemima Meyer.
Jemima Meyer began developing tools to help herself and other clinicians identify and treat patients more quickly, which ultimately led the pair to build Healthleap around proactive and preventive clinical screening.
KEY QUOTES:
“Every week, millions of patients leave hospitals with unresolved health conditions that will erode their health and cost up to 10x more to treat later. Finding them now is prevention, and it’s a win for everyone. Patients get treated before they get sicker. Hospitals shorten stays and are paid for the care they deliver. Payers avoid the much larger cost of complications down the road. Our goal is to improve care and save lives by catching these conditions early.”
Josiah Meyer, Co-Founder and CEO of Healthleap
“Healthleap is focused on finding patients who are being missed and getting them the care they need. The impact for both patients and hospitals has been inspiring, with one hospital seeing 39% more malnutrition cases identified and treated, and $11 million in incremental revenue in a single health system.”
Alfred Lin, Partner at Sequoia Capital
“We were immediately drawn to Healthleap’s bold vision: imagine if every hospital could use real-time AI to spot overlooked clinical risk, improve patient care, and unlock meaningful reimbursement revenue. That’s exactly what Healthleap is delivering and more, starting with disease-related malnutrition and rapidly expanding across conditions to save lives and hospitals money.”
Josh Kopelman, Co-Founder and Partner at First Round Capital
